Cargando…

505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study

BACKGROUND: Evidence regarding the impact of remdesivir (RDV) on SARS-CoV-2 viral clearance (VC) is scarce. Aim of this study was to compare VC timing in COVID-19 patients who received RDV with those who did not. METHODS: Matched-cohort study conducted (25 February 2020-15 April 2021) at the IRCSS S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spagnuolo, Vincenzo, Voarino, Marta, Tonelli, Marco, Galli, Laura, Poli, Andrea, Bruzzesi, Elena, Racca, Sara, Clementi, Nicola, Oltolini, Chiara, Tresoldi, Moreno, Querini, Patrizia Rovere, Dagna, Lorenzo, Zangrillo, Alberto, Ciceri, Fabio, Clementi, Massimo, Castagna, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644947/ http://dx.doi.org/10.1093/ofid/ofab466.704

Ejemplares similares

Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2022)

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
por: Spagnuolo, V., et al.
Publicado: (2020)

Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
por: Spagnuolo, V., et al.
Publicado: (2021)

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
por: Ripa, Marco, et al.
Publicado: (2021)

High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
por: Ripa, Marco, et al.
Publicado: (2022)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy
por: Ciceri, Fabio, et al.
Publicado: (2020)

Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
por: Ciceri, Fabio, et al.
Publicado: (2023)

Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2020)

Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2021)

COVID-19: Pharmacology and kinetics of viral clearance
por: Farina, Nicola, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection
por: Muccini, Camilla, et al.
Publicado: (2022)

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
por: Cavalli, Giulio, et al.
Publicado: (2020)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome
por: Ranzenigo, Martina, et al.
Publicado: (2021)

Pulmonary Vascular Thrombosis in COVID-19 Pneumonia
por: De Cobelli, Francesco, et al.
Publicado: (2021)

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19
por: Di Filippo, Luigi, et al.
Publicado: (2020)

Is Bordetella pertussis co-infecting SARS-CoV-2 patients?
por: Renzi, Samuele, et al.
Publicado: (2020)

Combined plasma levels of IL‐10 and testosterone, but not soluble HLA‐G5, predict the risk of death in COVID‐19 patients
por: Amodio, Giada, et al.
Publicado: (2022)

Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study
por: Conte, Caterina, et al.
Publicado: (2021)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
por: Ranzenigo, Martina, et al.
Publicado: (2022)

Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes
por: GORI, MARIA, et al.
Publicado: (2022)

Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study
por: De Lorenzo, Rebecca, et al.
Publicado: (2020)

Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients
por: Mushtaq, Junaid, et al.
Publicado: (2020)

Stranger Months: How SARS-CoV-2, Fear of Contagion, and Lockdown Measures Impacted Attendance and Clinical Activity During February and March 2020 at an Urban Emergency Department in Milan
por: Franchini, Stefano, et al.
Publicado: (2020)

505 Verdades publicitarias /
por: Pratt Gaballí, Pedro
Publicado: (2001)

Achieving virological control in pan-resistant HIV-1 infection: A case series
por: Canetti, Diana, et al.
Publicado: (2022)

Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study
por: De Lorenzo, Rebecca, et al.
Publicado: (2022)

The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key?
por: Sciorati, Clara, et al.
Publicado: (2023)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
por: Clementi, Nicola, et al.
Publicado: (2020)

Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
por: Oltolini, Chiara, et al.
Publicado: (2023)

Post-COVID-19 follow-up clinic: depicting chronicity of a new disease
por: Rovere-Querini, Patrizia, et al.
Publicado: (2020)

Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial
por: Bosi, Emanuele, et al.
Publicado: (2020)

Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
por: Zangrillo, Alberto, et al.
Publicado: (2023)

Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection
por: Lanzani, Chiara, et al.
Publicado: (2021)

SUN-505 The Invincible Parathyroid Gland
por: Mayorga, Mabel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vgmd64gaske7fln62lttkn8c1f